0	10	Phenotypic	Phenotypic	JJ	B-NP
11	19	analysis	analysis	NN	I-NP
20	32	demonstrates	demonstrate	VBZ	B-VP
33	37	that	that	IN	B-SBAR
38	42	trio	trio	NN	B-NP
43	46	and	and	CC	I-NP
47	50	Abl	Abl	NN	I-NP
51	60	cooperate	cooperate	VBP	B-VP
61	63	in	in	IN	B-PP
64	74	regulating	regulate	VBG	B-VP
75	79	axon	axon	NN	B-NP
80	89	outgrowth	outgrowth	NN	I-NP
90	92	in	in	IN	B-PP
93	96	the	the	DT	B-NP
97	106	embryonic	embryonic	JJ	I-NP
107	114	central	central	JJ	I-NP
115	122	nervous	nervous	JJ	I-NP
123	129	system	system	NN	I-NP
130	131	(	(	(	O
131	134	CNS	CNS	NN	B-NP
134	135	)	)	)	O
135	136	.	.	.	O

0	2	In	In	IN	B-PP
3	6	the	the	DT	B-NP
7	15	cervical	cervical	JJ	I-NP
16	27	enlargement	enlargement	NN	I-NP
28	32	they	they	PRP	B-NP
33	37	were	be	VBD	B-VP
38	45	located	locate	VBN	I-VP
46	48	in	in	IN	B-PP
49	52	the	the	DT	B-NP
53	59	middle	middle	JJ	I-NP
60	64	part	part	NN	I-NP
65	67	of	of	IN	B-PP
68	74	lamina	lamina	NN	B-NP
75	78	VII	VII	CD	I-NP
79	82	and	and	CC	O
83	85	in	in	IN	B-PP
86	92	lamina	lamina	NN	B-NP
93	97	VIII	VIII	CD	I-NP
97	98	,	,	,	O
99	109	accounting	account	VBG	B-VP
110	113	for	for	IN	B-PP
114	119	about	about	IN	B-NP
120	122	25	25	CD	I-NP
122	123	%	%	NN	I-NP
124	126	of	of	IN	B-PP
127	130	the	the	DT	B-NP
131	136	total	total	JJ	I-NP
137	144	labeled	label	VBN	I-NP
145	152	neurons	neuron	NNS	I-NP
152	153	.	.	.	O

0	2	We	We	PRP	B-NP
3	11	measured	measure	VBD	B-VP
12	27	electromyograms	electromyogram	NNS	B-NP
28	29	(	(	(	O
29	32	EMG	EMG	NN	B-NP
32	33	)	)	)	O
34	36	of	of	IN	B-PP
37	40	the	the	DT	B-NP
41	45	alae	alae	JJ	I-NP
46	50	nasi	nasi	NNS	I-NP
51	53	to	to	TO	B-VP
54	63	determine	determine	VB	I-VP
64	67	the	the	DT	B-NP
68	80	relationship	relationship	NN	I-NP
81	88	between	between	IN	B-PP
89	94	their	their	PRP$	B-NP
95	103	activity	activity	NN	I-NP
104	107	and	and	CC	I-NP
108	114	timing	timing	NN	I-NP
115	117	to	to	TO	B-PP
118	129	contraction	contraction	NN	B-NP
130	132	of	of	IN	B-PP
133	136	the	the	DT	B-NP
137	140	rib	rib	NN	I-NP
141	145	cage	cage	NN	I-NP
146	153	muscles	muscle	NNS	I-NP
154	157	and	and	CC	O
158	167	diaphragm	diaphragm	NN	B-NP
168	174	during	during	IN	B-PP
175	186	obstructive	obstructive	JJ	B-NP
187	192	apnea	apnea	NN	I-NP
193	195	in	in	IN	B-PP
196	200	nine	nine	CD	B-NP
201	209	patients	patient	NNS	I-NP
209	210	.	.	.	O

0	1	A	A	DT	B-NP
2	6	case	case	NN	I-NP
7	14	control	control	NN	I-NP
15	20	study	study	NN	I-NP
21	22	(	(	(	O
22	23	1	1	CD	B-NP
23	24	:	:	SYM	O
24	25	2	2	CD	O
25	26	)	)	)	O
27	29	of	of	IN	B-PP
30	33	182	182	CD	B-NP
34	39	pairs	pair	NNS	I-NP
40	42	of	of	IN	B-PP
43	52	Hepatitis	Hepatitis	NN	B-NP
53	54	A	A	NN	I-NP
55	58	was	be	VBD	B-VP
59	66	carried	carry	VBN	I-VP
67	70	out	out	RP	B-PRT
71	73	in	in	IN	B-PP
74	78	Weng	Weng	NN	B-NP
78	79	-	-	HYPH	O
79	83	ling	le	VBG	B-VP
84	87	Zhe	Zhe	NN	B-NP
87	88	-	-	HYPH	B-NP
88	93	jiang	jiang	NN	I-NP
94	100	during	during	IN	B-PP
101	106	April	April	NNP	B-NP
107	111	1988	1988	CD	I-NP
111	112	.	.	.	O

0	2	In	In	IN	B-PP
3	6	the	the	DT	B-NP
7	14	absence	absence	NN	I-NP
15	17	of	of	IN	B-PP
18	23	shock	shock	NN	B-NP
23	24	,	,	,	O
25	31	sepsis	sepsis	NN	B-NP
31	32	,	,	,	O
33	35	or	or	CC	O
36	41	other	other	JJ	B-NP
42	54	identifiable	identifiable	JJ	I-NP
55	61	causes	cause	NNS	I-NP
62	64	of	of	IN	B-PP
65	71	lactic	lactic	JJ	B-NP
72	80	acidosis	acidosis	NN	I-NP
80	81	,	,	,	O
82	85	the	the	DT	B-NP
86	92	severe	severe	JJ	I-NP
93	99	anemia	anemia	NN	I-NP
100	101	(	(	(	O
101	111	hemoglobin	hemoglobin	NN	B-NP
112	113	1	1	CD	I-NP
113	114	.	.	.	O
114	115	2	2	CD	B-NP
116	117	g	g	NN	I-NP
117	118	/	/	SYM	B-NP
118	120	dl	dl	NN	I-NP
120	121	)	)	)	O
122	130	appeared	appear	VBD	B-VP
131	133	to	to	TO	I-VP
134	136	be	be	VB	I-VP
137	140	the	the	DT	B-NP
141	148	primary	primary	JJ	I-NP
149	158	etiologic	etiologic	JJ	I-NP
159	165	factor	factor	NN	I-NP
165	166	.	.	.	O

0	7	However	However	RB	B-ADVP
8	11	the	the	DT	B-NP
12	19	precise	precise	JJ	I-NP
20	28	function	function	NN	I-NP
29	31	of	of	IN	B-PP
32	35	DNA	DNA	NN	B-NP
35	36	-	-	HYPH	B-NP
36	38	PK	PK	NN	I-NP
39	41	in	in	IN	B-PP
42	45	DNA	DNA	NN	B-NP
46	52	double	double	JJ	I-NP
52	53	-	-	HYPH	I-NP
53	59	strand	strand	NN	I-NP
60	65	break	break	NN	I-NP
66	72	repair	repair	NN	I-NP
73	75	is	be	VBZ	B-VP
76	79	not	not	RB	I-VP
80	85	known	know	VBN	I-VP
85	86	.	.	.	O

0	3	The	The	DT	B-NP
4	7	COR	COR	NN	I-NP
8	20	biosynthetic	biosynthetic	JJ	I-NP
21	25	gene	gene	NN	I-NP
26	33	cluster	cluster	NN	I-NP
34	36	in	in	IN	B-PP
37	38	P	P	NN	B-NP
38	39	.	.	.	O
40	48	syringae	syringae	JJ	B-NP
49	51	pv	pv	NN	I-NP
51	52	.	.	.	O
53	61	glycinea	glycinea	NN	B-NP
62	68	PG4180	PG4180	NN	I-NP
69	71	is	be	VBZ	B-VP
72	79	encoded	encode	VBN	I-VP
80	82	by	by	IN	B-PP
83	84	a	a	DT	B-NP
85	87	32	32	CD	I-NP
87	88	-	-	HYPH	I-NP
88	90	kb	kb	NN	I-NP
91	97	region	region	NN	I-NP
98	103	which	which	WDT	B-NP
104	112	contains	contain	VBZ	B-VP
113	117	both	both	CC	O
118	121	the	the	DT	B-NP
122	132	structural	structural	JJ	I-NP
133	136	and	and	CC	I-NP
137	147	regulatory	regulatory	JJ	I-NP
148	153	genes	gene	NNS	I-NP
154	160	needed	need	VBN	B-VP
161	164	for	for	IN	B-PP
165	168	COR	COR	NN	B-NP
169	178	synthesis	synthesis	NN	I-NP
178	179	.	.	.	O

0	12	Substitution	Substitution	NN	B-NP
13	15	of	of	IN	B-PP
16	27	cholinergic	cholinergic	JJ	B-NP
28	33	drugs	drug	NNS	I-NP
34	36	in	in	IN	B-PP
37	40	the	the	DT	B-NP
41	50	treatment	treatment	NN	I-NP
51	53	of	of	IN	B-PP
54	63	Alzheimer	Alzheimer	NNP	B-NP
64	68	type	type	NN	I-NP
69	77	dementia	dementia	NN	I-NP
78	79	(	(	(	O
79	81	AD	AD	NN	B-NP
81	82	/	/	SYM	B-NP
82	86	SDAT	SDAT	NN	I-NP
86	87	)	)	)	O
88	91	has	have	VBZ	B-VP
92	100	hitherto	hitherto	VBN	I-VP
101	104	not	not	RB	I-VP
105	109	been	be	VBN	I-VP
110	114	very	very	RB	B-ADJP
115	125	successful	successful	JJ	I-ADJP
125	126	.	.	.	O

0	6	FEurea	FEurea	NNP	B-NP
7	10	was	be	VBD	B-VP
11	15	also	also	RB	I-VP
16	24	measured	measure	VBN	I-VP
25	31	during	during	IN	B-PP
32	38	stable	stable	JJ	B-NP
39	44	graft	graft	NN	I-NP
45	53	function	function	NN	I-NP
53	54	,	,	,	O
55	56	7	7	CD	B-NP
56	57	-	-	HYPH	I-NP
57	59	14	14	CD	I-NP
60	64	days	day	NNS	I-NP
65	70	prior	prior	RB	B-ADVP
71	73	to	to	TO	B-PP
74	83	allograft	allograft	NN	B-NP
84	95	dysfunction	dysfunction	NN	I-NP
95	96	.	.	.	O

0	3	The	The	DT	B-NP
4	12	findings	finding	NNS	I-NP
13	16	are	be	VBP	B-VP
17	26	discussed	discuss	VBN	I-VP
27	31	with	with	IN	B-PP
32	41	reference	reference	NN	B-NP
42	44	to	to	TO	B-PP
45	53	possible	possible	JJ	B-NP
54	64	mechanisms	mechanism	NNS	I-NP
65	67	by	by	IN	B-PP
68	73	which	which	WDT	B-NP
74	82	parasite	parasite	JJ	B-NP
83	94	development	development	NN	I-NP
95	100	might	might	MD	B-VP
101	103	be	be	VB	I-VP
104	114	controlled	control	VBN	I-VP
114	115	.	.	.	O

